User login
- /content/less-lenalidomide-may-be-more-frail-elderly-multiple-myeloma-patients
- /fedprac/article/143399/hematologic-malignancies/less-lenalidomide-may-be-more-frail-elderly-multiple
- /hematologynews/article/143399/hematologic-malignancies/less-lenalidomide-may-be-more-frail-elderly
- /oncologypractice/article/143399/hematologic-malignancies/less-lenalidomide-may-be-more-frail-elderly
- /fedprac/avaho/article/143399/hematologic-malignancies/less-lenalidomide-may-be-more-frail-elderly
- /hematology-oncology/article/143399/hematologic-malignancies/less-lenalidomide-may-be-more-frail